Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2026-06-10 18:21:32 ET · period of report 2026-06-09 · accession 0001628280-26-042326 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-06-10 18:21 | 2026-06-09 | VIR | Coughlin Timothy | Dir | A - Grant | $0.00 | +16.0K | 16.0K | New | $0 |
| DM | 2026-06-10 18:21 | 2026-06-09 | VIR | Coughlin Timothy | Dir | A - Grant | $0.00 | +32.0K | 16.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-09 | A | A | 8,000 | $0.00 | 8,000 | D | — | — | (F1) Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan. (F2) 1/3 of the RSUs will vest on June 9, 2027, and the remaining RSUs will vest in two equal annual installments thereafter. |
| 2 | Common | Common Stock | 2026-06-09 | A | A | 8,000 | $0.00 | 16,000 | D | — | — | (F1) Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan. (F3) The RSUs will vest in full on the earlier of (i) June 9, 2027, or (ii) the date of the Issuer's next annual meeting of stockholders. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-06-09 | A | A | 16,000 | $0.00 | 16,000 | D | $8.51 · — to 2036-06-08 | 16,000 Common Stock | (F4) 1/3 of the shares subject to the stock option will vest and become exercisable on June 9, 2027, and the remaining shares will vest and become exercisable in 24 equal monthly installments thereafter. |
| 4 | Derivative | Stock Option (Right to Buy) | 2026-06-09 | A | A | 16,000 | $0.00 | 16,000 | D | $8.51 · — to 2036-06-08 | 16,000 Common Stock | (F5) The shares subject to the stock option vest and become exercisable in full on the earlier of (i) June 9, 2027, or (ii) the date of the Issuer's next annual meeting of stockholders. |